Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
18 results
  • Head and Neck Cancer, Sarcoma, Leukemia, Ovarian Cancer, Breast Cancer, Lymphoma, Metastatic/Advanced Cancer

20-035          Phase II

A Multi-Center, Open Label Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in Patients With Relapsed/Refractory B-Cell Malignancies and Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Lymphoma, Leukemia, Cellular Therapy

22-262          Phase I

A Phase 1, Multicenter, Open-label Study of BMS-986403 in Subjects With Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) (View details on clinicaltrial.gov)

  • Myelodysplastic Syndromes, Leukemia

14-191          Phase I

A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients with Hematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 with and without Ruxolitinib in Patients with Myelofibrosis) (View details on clinicaltrial.gov)

  • Leukemia

21-706          Phase II

A PHASE 1B, OPEN-LABEL, GLOBAL, MULTICENTER, DOSE DETERMINATION STUDY TO EVALUATE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF CC-486 (ONUREG®) IN COMBINATION THERAPY IN SUBJECTS WITH ACUTE MYELOID LEUKEMIA (AML) (View details on clinicaltrial.gov)

  • Leukemia

21-113          Phase II

A Phase 2 Randomized Study Comparing Venetoclax and Azacitidine to Induction Chemotherapy for Newly Diagnosed Fit Adults with Acute Myeloid Leukemia (View details on clinicaltrial.gov)

  • Leukemia

21-132          Phase II

A Phase 2, Open-Label, Multicenter, Rollover Study to Provide Continued Treatment for Participants With Advanced Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465) (View details on clinicaltrial.gov)

  • Leukemia

21-374          Phase III

A Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination with Azacitidine versus Physician’s Choice of Venetoclax in Combination with Azacitidine or Intensive Chemotherapy in Previously Untreated Patients with TP53 Mutant Acute Myeloid Leukemia (View details on clinicaltrial.gov)

Showing 1 - 10 of 18 results